John Wilkin
Stock Analyst at Craig-Hallum
(2.44)
# 2,375
Out of 5,154 analysts
5
Total ratings
60%
Success rate
14.36%
Average return
Main Sectors:
Top Industries:
Stocks Rated by John Wilkin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XGN Exagen | Initiates: Buy | $12 | $3.29 | +264.74% | 1 | Jul 23, 2025 | |
| ADPT Adaptive Biotechnologies | Initiates: Buy | $15 | $14.86 | +0.94% | 1 | Jun 18, 2025 | |
| VCYT Veracyte | Initiates: Buy | $45 | $33.85 | +32.94% | 1 | Mar 20, 2025 | |
| PSNL Personalis | Initiates: Buy | $8 | $7.84 | +2.04% | 1 | Mar 17, 2025 | |
| MYGN Myriad Genetics | Initiates: Buy | $29 | $5.15 | +463.11% | 1 | Feb 12, 2025 |
Exagen
Jul 23, 2025
Initiates: Buy
Price Target: $12
Current: $3.29
Upside: +264.74%
Adaptive Biotechnologies
Jun 18, 2025
Initiates: Buy
Price Target: $15
Current: $14.86
Upside: +0.94%
Veracyte
Mar 20, 2025
Initiates: Buy
Price Target: $45
Current: $33.85
Upside: +32.94%
Personalis
Mar 17, 2025
Initiates: Buy
Price Target: $8
Current: $7.84
Upside: +2.04%
Myriad Genetics
Feb 12, 2025
Initiates: Buy
Price Target: $29
Current: $5.15
Upside: +463.11%